GRIP Molecular Technologies Inc. filed an amended Form D with the Securities and Exchange Commission on 2026-10-29.
GRIP Molecular Technologies Inc. filed an amended Form D notice of an exempt securities offering with the SEC on October 29, 2026. The filing reports $11.79M sold. Its industry group is Other Technology. It names Bruce Batten (Chief Scientific Officer), Edward Ludwig (Director), Richard Minicus (CFO) (SEC Form D/A, October 29, 2026).
Is this your company?
Sell to companies like GRIP Molecular Technologies Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-29 · the record
Pitching, partnering or investing alongside them? See who really runs and owns GRIP Molecular Technologies Inc.
Free to see. No signup.
More on the people and the money behind GRIP Molecular Technologies Inc., from the filings we hold.
Other Technology raises by companies based in Minnesota, filed in October 2026, largest first.
Get an email when GRIP Molecular Technologies Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when GRIP Molecular Technologies Inc. raises, hires or launches. No email unless you switch it on.
Watch GRIP Molecular Technologies Inc. →Get the full cited report on GRIP Molecular Technologies Inc.
What the filing shows about GRIP Molecular Technologies Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on GRIP Molecular Technologies Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives GRIP Molecular Technologies Inc.'s address as 1000 Westgate Drive, Saint Paul, MN 55114.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for GRIP Molecular Technologies Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on GRIP Molecular Technologies Inc. See pricing
GRIP Molecular Technologies Inc. is a registered filer with the SEC (CIK 1797600) and has filed since 2023-05-30. 4 filings are on record, the latest on 2026-10-29.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
GRIP Molecular Technologies Inc.'s Form D of 2026-10-29 names Bruce Batten, Edward Ludwig, Richard Minicus and 1 more as its officers, directors or promoters.
Its new offerings report $500K sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 3844 filings in Other Technology, totalled by week. The dot is this raise, $11.79M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
GRIP Molecular Technologies is pioneering a molecular test for lateral flow assay readouts with a CRISPR protease-based platform.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer.
Bruce Batten is named as Chief Scientific Officer on the Form D that GRIP Molecular Technologies Inc. filed with the SEC on 29 October 2026, one of 4 people that filing names.
Edward Ludwig is named as Director on the Form D that GRIP Molecular Technologies Inc. filed with the SEC on 29 October 2026, one of 4 people that filing names.
On the filing as: Executive Officer.
Richard Minicus is named as Cfo on the Form D that GRIP Molecular Technologies Inc. filed with the SEC on 29 October 2026, one of 4 people that filing names.
Edward Gillen is named as Executive Officer on the Form D that GRIP Molecular Technologies Inc. filed with the SEC on 29 October 2026, one of 4 people that filing names.
4 people named on the filing — 3 holding an executive role and 1 as a director only.
Named as of the 2026-10-29 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about GRIP Molecular Technologies Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on GRIP Molecular Technologies Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on GRIP Molecular Technologies Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist GRIP Molecular Technologies Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind GRIP Molecular Technologies Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-30 (gripmolecular.com).
Each opens in a new tab, filled in for GRIP Molecular Technologies Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/grip-molecular-technologies-inc-form-d-000002